QLY BIOTECH GROUP CORP.

EDGAR

Market value is not computed: no recent price is available.

15 filing records in this dataset, filed from 2019-10-09 to 2023-04-13. Reported financial figures are available; chart coverage varies by period.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

No Form 3, 4 or 5 for this issuer is in the store. The store has read filings dated 2004-06-14 to 2026-11-18; this is not a statement that none were filed.

See all insider transactions

Latest quarter

Revenue

0 USD

2023 Q2 · USD

Exact inputs and evidence

Operating cash flow

-10.3 thousand USD

2023 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: -15937 USD Source
  • Operating Cash Flow: -5668 USD Source
Cash and cash equivalents
0 USD Source
Exact value

0 USD

Long-term debt including current maturities
Not available
Shares outstanding
3.9 million shares Source
Exact value

3895000 shares

Reported share-count change

0.00% · 0 shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 3895000 shares · 2022-02-28· Source
  • 3895000 shares · 2023-02-28· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

0 USD

2022-03-01 – 2023-02-28

Exact inputs and evidence
  • Revenue: 0 USD · 2022-03-01 – 2022-05-31 Source
  • Revenue: 0 USD · 2021-09-01 – 2022-08-31 Source
  • Revenue: 0 USD · 2021-09-01 – 2022-05-31 Source
  • Revenue: 0 USD · 2022-09-01 – 2022-11-30 Source
  • Revenue: 0 USD · 2022-12-01 – 2023-02-28 Source

Net income

-28.9 thousand USD

2022-03-01 – 2023-02-28

Exact inputs and evidence
  • Net income: -3305 USD · 2022-03-01 – 2022-05-31 Source
  • Net income: -14112 USD · 2021-09-01 – 2022-08-31 Source
  • Net income: -9272 USD · 2021-09-01 – 2022-05-31 Source
  • Net income: -9168 USD · 2022-09-01 – 2022-11-30 Source
  • Net income: -11620 USD · 2022-12-01 – 2023-02-28 Source

Operating cash flow

-23.5 thousand USD

2022-03-01 – 2023-02-28

Exact inputs and evidence
  • Operating cash flow: -10011 USD · 2021-09-01 – 2022-05-31 Source
  • Operating cash flow: -6636 USD · 2021-09-01 – 2022-02-28 Source
  • Operating cash flow: -14210 USD · 2021-09-01 – 2022-08-31 Source
  • Operating cash flow: -10011 USD · 2021-09-01 – 2022-05-31 Source
  • Operating cash flow: -5668 USD · 2022-09-01 – 2022-11-30 Source
  • Operating cash flow: -15937 USD · 2022-09-01 – 2023-02-28 Source
  • Operating cash flow: -5668 USD · 2022-09-01 – 2022-11-30 Source

Capital expenditure

0 USD

2020-09-01 – 2021-08-31

Exact inputs and evidence
  • Capital expenditure: 0 USD · 2020-09-01 – 2020-11-30 Source
  • Capital expenditure: 0 USD · 2020-09-01 – 2021-02-28 Source
  • Capital expenditure: 0 USD · 2020-09-01 – 2020-11-30 Source
  • Capital expenditure: 0 USD · 2020-09-01 – 2021-05-31 Source
  • Capital expenditure: 0 USD · 2020-09-01 – 2021-02-28 Source
  • Capital expenditure: 0 USD · 2020-09-01 – 2021-08-31 Source
  • Capital expenditure: 0 USD · 2020-09-01 – 2021-05-31 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-04-13.

Financial data available through: 2022-08-31.

Coverage by financial measure
  • Revenue: 4 of 11 periods available· newest 2022-08-31
  • Operating income: 3 of 11 periods available· newest 2022-08-31
  • Net income: 4 of 11 periods available· newest 2022-08-31
  • Operating cash flow: 4 of 11 periods available· newest 2022-08-31
  • Capital expenditure: 3 of 11 periods available· newest 2021-08-31
  • Total assets: 4 of 11 periods available· newest 2022-08-31
  • Total liabilities: 4 of 11 periods available· newest 2022-08-31
  • Current assets: 4 of 11 periods available· newest 2022-08-31
  • Current liabilities: 4 of 11 periods available· newest 2022-08-31
  • Cash and cash equivalents: 4 of 11 periods available· newest 2022-08-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 4 of 11 periods available· newest 2022-08-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    -100%

    Prior period

    USD 4,000

    –

    Current period

    USD 0

    –

    Exact inputs and evidence

    0 − 4000 = -4000 USD

    4000 USD · 2020-09-01 – 2021-08-31

    Inspect prior input Prior source

    0 USD · 2021-09-01 – 2022-08-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +USD 15,391

    Prior period

    −USD 29,503

    –

    Current period

    −USD 14,112

    –

    Exact inputs and evidence

    -14112 − -29503 = 15391 USD

    -29503 USD · 2020-09-01 – 2021-08-31

    Inspect prior input Prior source

    -14112 USD · 2021-09-01 – 2022-08-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 12,055

    Prior period

    −USD 26,265

    –

    Current period

    −USD 14,210

    –

    Exact inputs and evidence

    -14210 − -26265 = 12055 USD

    -26265 USD · 2020-09-01 – 2021-08-31

    Inspect prior input Prior source

    -14210 USD · 2021-09-01 – 2022-08-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2021-09-01 – 2022-08-31

  • Revenue USD 0
  • Operating costs Derived −USD 14,112
  • Operating income USD 14,112
  • Tax, interest and other Derived USD 28,224
  • Net income −USD 14,112

Cash

  • Operating cash flow −USD 14,210
  • Capital expenditure Unavailable An input is unavailable.
  • Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2019 Not shown: operating income or net income is not reported.
  • 2020 Net loss: net income was −133% of revenue.
  • 2021 Net loss: net income was −738% of revenue.
  • 2022 Not shown: operating income or net income is not reported.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2019 2018-09-20 – 2019-08-310 UnavailableUnavailableUnavailable-978 -978 Derived
Source
2020 2019-09-01 – 2020-08-314000 -2310 Derived 6310 11642 Derived -5332 -9035 Derived
Source
2021 2020-09-01 – 2021-08-314000 -25503 Derived 29503 59006 Derived -29503 -26265 Derived
Source
2022 2021-09-01 – 2022-08-310 -14112 Derived 14112 28224 Derived -14112 Unavailable
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2022
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.4.3K3.2K2.2K1.1K0.02019202020212022
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2019Revenue0
2020Revenue4000
2021Revenue4000
2022Revenue0

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2022
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.8%-21%-50%-79%-108%2019202020212022
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2019Year over yearNo prior comparable period
2020Year over yearNo prior comparable period
2021Year over year0%
2022Year over year-100%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 737.6% 2021
Net margin -737.6% 2021
Free cash flow margin -656.6% 2021
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.856%428%0%-428%-856%2019-08-31202020212022
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2019-08-31Operating marginNot reported
2020Operating margin157.8%
2021Operating margin737.6%
2022Operating marginNot reported
2019-08-31Net marginNot reported
2020Net margin-133.3%
2021Net margin-737.6%
2022Net marginNot reported
2019Free cash flow marginNot reported
2020Free cash flow margin-225.9%
2021Free cash flow margin-656.6%
2022Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

USD -14.2K 2022
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.2.1K-5.5K-13.1K-20.7K-28.4K2019202020212022
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2019Operating cash flow-978
2020Operating cash flow-3896
2021Operating cash flow-26265
2022Operating cash flow-14210

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -26.3K 2021
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.2.1K-5.5K-13.1K-20.7K-28.4K2019202020212022
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2019Free cash flow-978
2020Free cash flow-9035
2021Free cash flow-26265
2022Free cash flowUnavailable

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

183.3% 2021
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.198%148%99%49%0%2019202020212022
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2019Liabilities / assets59.6%
2020Liabilities / assets24.9%
2021Liabilities / assets183.3%
2022Liabilities / assetsNot reported

Current assets to current liabilities

Current assets divided by current liabilities.

0.39× 2021
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.3.83×2.87×1.91×0.96×0.00×2019202020212022
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2019Current assets / current liabilities1.68×
2020Current assets / current liabilities3.54×
2021Current assets / current liabilities0.39×
2022Current assets / current liabilitiesNot reported

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2019 2018-09-20 – 2019-08-31
−USD 978
Exact value

Exact value: -978 USD

2018-09-20 – 2019-08-31: -978 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 978
Exact value

Exact value: -978 USD

2018-09-20 – 2019-08-31: -978 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 0
Exact value

Exact value: 0 USD

2018-09-20 – 2019-08-31: 0 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 978
Calculation and evidence

-978 − 0 USD

Exact free cash flow: -978 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2019 2018-09-21 – 2019-08-31
−USD 978
Exact value

Exact value: -978 USD

2018-09-21 – 2019-08-31: -978 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

2020 2019-09-01 – 2020-08-31
−USD 5,332
Exact value

Exact value: -5332 USD

2019-09-01 – 2020-08-31: -5332 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 3,896
Exact value

Exact value: -3896 USD

2019-09-01 – 2020-08-31: -3896 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 5,139
Exact value

Exact value: 5139 USD

2019-09-01 – 2020-08-31: 5139 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 9,035
Calculation and evidence

-3896 − 5139 USD

Exact free cash flow: -9035 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2020-09-01 – 2021-08-31
−USD 29,503
Exact value

Exact value: -29503 USD

2020-09-01 – 2021-08-31: -29503 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 26,265
Exact value

Exact value: -26265 USD

2020-09-01 – 2021-08-31: -26265 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 0
Exact value

Exact value: 0 USD

2020-09-01 – 2021-08-31: 0 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 26,265
Calculation and evidence

-26265 − 0 USD

Exact free cash flow: -26265 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2021-09-01 – 2022-08-31
−USD 14,112
Exact value

Exact value: -14112 USD

2021-09-01 – 2022-08-31: -14112 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 14,210
Exact value

Exact value: -14210 USD

2021-09-01 – 2022-08-31: -14210 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

15 filings · 644 latest values · 644 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001787123, 1787123, LQLY, edgar:1787123

Also known as AZAR INTERNATIONAL CORP., Azar International Corp., QLY BIOTECH GROUP CORP., QLY Biotech Group Corp.